CUTANEOUS T-CELL LYMPHOMA

This adverse event was reported 1260 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA:

# Drug Count
0 DUPILUMAB 357
1 METHOTREXATE SODIUM 153
2 METHOTREXATE 127
3 ADALIMUMAB 105
4 PREDNISONE 87
5 USTEKINUMAB 70
6 CYCLOSPORINE 63
7 UPADACITINIB 63
8 SECUKINUMAB 59
9 MYCOPHENOLATE MOFETIL 58
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA

CUTANEOUS T-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MECHLORETHAMINE HYDROCHLORIDE 47 0.0209
1 BEXAROTENE 27 0.0204
2 DELGOCITINIB 3 0.0112
3 ACITRETIN 40 0.0081
4 ROMIDEPSIN 12 0.0071
5 BRODALUMAB 14 0.0068
6 MOGAMULIZUMAB-KPKC 9 0.0066
7 ABROCITINIB 24 0.0061
8 DUVELISIB 4 0.0047
9 PRALATREXATE 3 0.0046
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA